Leica Biosystems PD-L1 BOND antibody
Leica Biosystems’ PD-L1 BOND antibody is designed for use on the company’s fully automated BOND IHC and ISH staining platform.
The PD-L1 (programmed death - ligand 1) antibody uses the MKP1A07310 (clone 73-10) expressed by Abcam on behalf of Merck KGaA, which owns all IP rights to this antibody. It joins the ALK (anaplastic lymphoma kinase) antibody as the latest addition to Novocastra’s growing lung menu of primary antibodies.
Leica Biosystems has optimised these two clones into a ready-to-use format for use on the BOND IHC and ISH staining platform. This allows labs to perform ALK and PD-L1 testing on the BOND system with rapid turnaround times, reliable staining and walk-away convenience.
Phone: 1800 625 286
Cayman Chemical Kinase Screening Library (96-Well)
Cayman Chemical's Kinase Screening Library (96-Well) consists of two plates and contains...
AdipoGen Life Sciences GLP-1, GIP and GCG receptor agonists
AdipoGen's range of GLP-1, GIP and GCG receptor agonists includes Liraglutide, Retatrutide,...
Integrated DNA Technologies xGen Hybridization and Wash v3 Kit
Integrated DNA Technologies (IDT) has unveiled its xGen Hybridization and Wash v3 Kit — a...
